Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SNK01 |
Trade Name | |
Synonyms | SNK-01|SNK 01 |
Drug Descriptions |
SNK01 is a modified autologous natural killer cell therapy, which potentially increases cytotoxicity against tumor cells (J. of Clin. Onc. 2020 38:15_suppl, e15024). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C178330 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AFM24 + SNK01 | AFM24 SNK01 | 0 | 1 |
Avelumab + SNK01 | Avelumab SNK01 | 0 | 1 |
Pembrolizumab + SNK01 | Pembrolizumab SNK01 | 0 | 1 |
SNK01 | SNK01 | 0 | 1 |